6-152425458-A-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):​c.5190T>A​(p.Asp1730Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0458 in 1,614,108 control chromosomes in the GnomAD database, including 1,838 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.045 ( 172 hom., cov: 33)
Exomes 𝑓: 0.046 ( 1666 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -2.22
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SYNE1. . Gene score misZ -0.29069 (greater than the threshold 3.09). Trascript score misZ 3.2909 (greater than threshold 3.09). GenCC has associacion of gene with autosomal recessive ataxia, Beauce type, autosomal recessive myogenic arthrogryposis multiplex congenita, Emery-Dreifuss muscular dystrophy 4, autosomal dominant, arthrogryposis multiplex congenita 3, myogenic type, autosomal dominant Emery-Dreifuss muscular dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0015822649).
BP6
Variant 6-152425458-A-T is Benign according to our data. Variant chr6-152425458-A-T is described in ClinVar as [Benign]. Clinvar id is 130446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152425458-A-T is described in Lovd as [Benign]. Variant chr6-152425458-A-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0536 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SYNE1NM_182961.4 linkuse as main transcriptc.5190T>A p.Asp1730Glu missense_variant 39/146 ENST00000367255.10 NP_892006.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkuse as main transcriptc.5190T>A p.Asp1730Glu missense_variant 39/1461 NM_182961.4 ENSP00000356224 P1Q8NF91-1
SYNE1ENST00000423061.6 linkuse as main transcriptc.5211T>A p.Asp1737Glu missense_variant 39/1461 ENSP00000396024
SYNE1ENST00000461872.6 linkuse as main transcriptn.5408T>A non_coding_transcript_exon_variant 37/551

Frequencies

GnomAD3 genomes
AF:
0.0447
AC:
6798
AN:
152166
Hom.:
170
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0343
Gnomad AMI
AF:
0.00989
Gnomad AMR
AF:
0.0393
Gnomad ASJ
AF:
0.0665
Gnomad EAS
AF:
0.00270
Gnomad SAS
AF:
0.0377
Gnomad FIN
AF:
0.0446
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0551
Gnomad OTH
AF:
0.0549
GnomAD3 exomes
AF:
0.0427
AC:
10739
AN:
251304
Hom.:
319
AF XY:
0.0437
AC XY:
5940
AN XY:
135820
show subpopulations
Gnomad AFR exome
AF:
0.0356
Gnomad AMR exome
AF:
0.0246
Gnomad ASJ exome
AF:
0.0669
Gnomad EAS exome
AF:
0.00130
Gnomad SAS exome
AF:
0.0361
Gnomad FIN exome
AF:
0.0498
Gnomad NFE exome
AF:
0.0541
Gnomad OTH exome
AF:
0.0467
GnomAD4 exome
AF:
0.0459
AC:
67119
AN:
1461824
Hom.:
1666
Cov.:
31
AF XY:
0.0460
AC XY:
33420
AN XY:
727216
show subpopulations
Gnomad4 AFR exome
AF:
0.0355
Gnomad4 AMR exome
AF:
0.0259
Gnomad4 ASJ exome
AF:
0.0666
Gnomad4 EAS exome
AF:
0.000630
Gnomad4 SAS exome
AF:
0.0360
Gnomad4 FIN exome
AF:
0.0478
Gnomad4 NFE exome
AF:
0.0489
Gnomad4 OTH exome
AF:
0.0449
GnomAD4 genome
AF:
0.0448
AC:
6815
AN:
152284
Hom.:
172
Cov.:
33
AF XY:
0.0440
AC XY:
3275
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.0346
Gnomad4 AMR
AF:
0.0392
Gnomad4 ASJ
AF:
0.0665
Gnomad4 EAS
AF:
0.00271
Gnomad4 SAS
AF:
0.0377
Gnomad4 FIN
AF:
0.0446
Gnomad4 NFE
AF:
0.0551
Gnomad4 OTH
AF:
0.0539
Alfa
AF:
0.0541
Hom.:
77
Bravo
AF:
0.0424
TwinsUK
AF:
0.0461
AC:
171
ALSPAC
AF:
0.0462
AC:
178
ESP6500AA
AF:
0.0415
AC:
183
ESP6500EA
AF:
0.0516
AC:
444
ExAC
AF:
0.0442
AC:
5363
Asia WGS
AF:
0.0320
AC:
111
AN:
3478
EpiCase
AF:
0.0543
EpiControl
AF:
0.0527

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingGeneDxJan 25, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesMar 07, 2016- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
not provided Benign:1
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Autosomal recessive ataxia, Beauce type Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.79
T
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.0070
DANN
Benign
0.81
DEOGEN2
Benign
0.090
T;.;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.034
N
LIST_S2
Benign
0.63
T;T;T
MetaRNN
Benign
0.0016
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.24
N;.;.
MutationTaster
Benign
1.0
N;N;N;N;N
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.19
N;.;N
REVEL
Benign
0.041
Sift
Benign
0.74
T;.;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
B;.;.
Vest4
0.048
MutPred
0.26
Gain of ubiquitination at K1733 (P = 0.1204);.;.;
MPC
0.12
ClinPred
0.00058
T
GERP RS
-6.3
Varity_R
0.038
gMVP
0.024

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs111250109; hg19: chr6-152746593; COSMIC: COSV55083556; COSMIC: COSV55083556; API